echoloc
Get started
echoloc/ Companies/ Structure Therapeutics

Structure Therapeutics Tech Stack

Clinical-stage biotech developing oral small molecule therapies for metabolic and cardiovascular disease

Biotechnology Research South San Francisco, California 51–200 employees Founded 2017 Public Company
structuretx.com LinkedIn

Structure Therapeutics is a public clinical-stage biotech company focused on small molecule GPCR-targeted treatments for chronic metabolic, cardiovascular, and pulmonary conditions. The company operates a research-heavy organization (22 research roles, 41 senior hires in the last 30 days) paired with a scaled clinical operations footprint (17 healthcare roles, 10 data roles) — a profile consistent with a company transitioning from discovery into multi-site global trials.

Tech Stack 23 technologies

Core StackSmartsheet AWS Python scikit-learn TensorFlow PyTorch Docker SAS Microsoft Project GROMACS Spotfire Shiny Medidata Rave LC-MS/MS ggplot2 Plotly Matplotlib Seaborn GCP Azure Box Medidata CDISC

What Structure Therapeutics Is Building

◆Challenges

  • Ensuring compliance with regulatory guidelines
  • Managing cro/cdmo relationships
  • Managing global clinical trials
  • Participant retention challenges
  • Data integration
  • Budget negotiations with clinical sites
  • Study execution with minimal supervision
  • Trial optimization
  • Managing complex cro agreements
  • Delivering quality clinical trials on time

▲Active Projects

  • Ai-powered data science tools for clinical research
  • Trial optimization tools
  • Small molecule cmc projects
  • In vivo pharmacology studies for target validation
  • In vivo studies in obesity and metabolic disease
  • Continuous improvement of quality systems
  • Global clinical trials
  • Investigator-initiated trials
  • Clinical database development and validation
  • Clinical trial execution

Hiring Activity

Accelerating75 roles · 75 in 30d

Department

Research
22
Healthcare
17
Data
10
Ops
10
Engineering
4
Legal
3
Manufacturing
3
Clinical
2

Seniority

Senior
41
Director
24
Principal
6
Manager
3
Mid
2
Junior
1

Notable leadership hires: Toxicology Director, Medical Director, Clinical Operations Director, Field Medical Lead

Company intelligence

Find more companies like Structure Therapeutics by tech stack, pain points and active projects

Get started free

About Structure Therapeutics

Structure Therapeutics develops oral small molecule therapies targeting chronic metabolic and cardiopulmonary diseases, with a pipeline focused on GPCR targets. The company operates as a clinical-stage enterprise executing multiple global trials while maintaining active in vivo pharmacology and chemistry work. The organization spans research, clinical operations, data science, manufacturing, and regulatory functions. Based in South San Francisco with hiring activity in the United States and China, the company was founded in 2017 and is publicly listed.

HeadquartersSouth San Francisco, California
Company Size51–200 employees
Founded2017
Hiring MarketsChina, United States

Frequently Asked Questions

What is Structure Therapeutics' tech stack?

Computational chemistry (GROMACS, scikit-learn, TensorFlow, PyTorch), clinical trial management (Medidata Rave, CDISC, LC-MS/MS), analytics (SAS, Spotfire, Shiny, Plotly), cloud (AWS, GCP, Azure), and collaboration tools (Smartsheet, Microsoft Project, Box).

Where is Structure Therapeutics headquartered?

South San Francisco, California. The company also has hiring activity in China and the United States.

How this profile is built

Structure Therapeutics's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.